Daniel Wintner Goodman SEC EDGAR Filings (CIK 0001775914)

SEC EDGAR filings, ownership reports, and insider transactions for Daniel Wintner Goodman.

Business address
C/O Tonix Pharmaceuticals Holding Corp., 509 Madison Ave, New York, NY, 10022
Top holdings (ownership)
TNXP
Get insider transactions for this reporting owner
Daniel Wintner Goodman has filed 5 SEC EDGAR filings since 08 May 2019

Latest Filings

Recent SEC filings for Daniel Wintner Goodman including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 GOODMAN - CHANGES IN BENEFICIAL OWNERSHIP 26 May 2021 25 May 2021 001-36019
4 Open 4 document View SEC filing for 4 GOODMAN - CHANGES IN BENEFICIAL OWNERSHIP 12 May 2021 10 May 2021 001-36019
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 06 May 2020 04 May 2020 001-36019
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 08 May 2019 06 May 2019 001-36019
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 08 May 2019 06 May 2019 001-36019

About this filer

Daniel Wintner Goodman files with the SEC under CIK 0001775914. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages